New Industry Forum to Advance Clinical Trial Participation
Kearney, Neb., June 13, 2017-In 2018, the Bridging Clinical Research and Clinical Health Care Collaborative will bring together industry leaders from pharma, biotech, clinical research organizations, health care organizations, advocacy groups, and the FDA to advance the participation of patients and physicians in the conduct of clinical trials. The conference will be April 4–5 at the Gaylord National Resort and Conference Center in National Harbor, MD.
“Poor recruitment is the leading cause of failure in clinical trials. Less than 3 percent of patients and physicians participate,” said Cinda Orr, president and CEO of SCORR Marketing. “For quite some time, I have watched our industry try to determine how we can change this, but we have not made significant progress. As I am passionate about helping patients, I have established the Bridging Clinical Research and Clinical Health Care Collaborative with the support from health science colleagues and organizations so we can actualize a solution.”
The keynote speaker for the conference is Janet Woodcock, M.D., director of the Center for Drug Evaluation and Research at the U.S. Food and Drug Administration. Representing patients will be T.J. Sharpe, cancer survivor and patient advocate. Additional speakers have already been scheduled from 2bPrecise, Allscripts, HCA Healthcare, IBM Watson Health, INC Research and Sarah Cannon. Elligo Health Research, Allscripts, and INC Research are sponsors andApplied Clinical Trials, CenterWatch and FierceBiotech are media partners.
“This conference is at the core of what we do and we are proud to be a sponsor,” said John Potthoff, CEO at Elligo Health Research. “Just think what a significant impact we could make if we could get just an additional 3 percent of patients and physicians to participate. That would double the opportunity for patients to participate in clinical trials in the U.S.”
There are numerous ways to engage in the conference-attending, exhibiting, speaking or sponsoring. For more information on how to get involved, visit the website at www.bridgingclinical.com.
About Bridging Clinical Research and Clinical Health Care Collaborative
The Bridging Clinical Research and Clinical Health Care Collaborative is sponsored by SCORR Events, a division of SCORR Marketing, the leading marketing and communications firm in the health science industry. SCORR Events was established to provide education, collaboration and opportunities for industry professionals to advance health sciences.
CONTACT:
Lea Studer
SCORR Events
308-237-5567
lea@bridgingclinical.com
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Regulatory Compliance With eCOAs
April 26th 2024In the fourth and final part of this video interview with ACT editor Andy Studna, Melissa Mooney, director, eCOA sales engineering, IQVIA discusses how the regulatory stance on electronic clinical outcome assessments has changed over the years and what it could look like in the future.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
Using Patient Reported Outcomes in Dermatology Trials
April 25th 2024In part 3 of this video interview with ACT editor Andy Studna, Melissa Mooney, director, eCOA sales engineering, IQVIA sheds light on the unique challenges of dermatology trials and how clinical outcome assessments can be implemented in them.
